High androgen expression is linked to poor prognosis in male patients with muscle-invasive urothelial carcinoma of the bladder

被引：0

作者：

Plage, H. ^{[1
]}

Hofbauer, S. ^{[1
]}

Furlano, K. ^{[1
]}

Rossner, F. ^{[2
]}

Schallenberg, S. ^{[2
]}

Elezkurtaj, S. ^{[2
]}

Kluth, M. ^{[3
]}

Lennartz, M. ^{[3
]}

Marx, A. H. ^{[4
]}

Samtleben, H. ^{[4
]}

Fisch, M. ^{[5
]}

Rink, M. ^{[6
]}

Slojewski, M. ^{[7
]}

Kaczmarek, K. ^{[7
]}

Klatte, T. ^{[8
]}

Koch, S. ^{[9
]}

Burandt, E. ^{[3
]}

Minner, S. ^{[3
]}

Simon, R. ^{[3
]}

Sauter, G. ^{[3
]}

Zecha, H. ^{[10
]}

Schlomm, T. ^{[1
]}

Ecke, T. ^{[8
]}

机构：

[1] Charite Urol Berlin, Dept Urol, Berlin, Germany

[2] Charite Pathol Berlin, Dept Pathol, Berlin, Germany

[3] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany

[4] Acad Hosp Furth, Dept Pathol, Furth, Germany

[5] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany

[6] Marien Hosp, Dept Urol, Hamburg, Germany

[7] Pomeranian Med Univ, Dept Urol & Urol Oncol, Szczecin, Poland

[8] Helios Hosp, Dept Urol, Bad Saarow Pieskow, Germany

[9] Helios Hosp, Dept Pathol, Bad Saarow Pieskow, Germany

[10] Albertinen Hosp, Dept Urol, Hamburg, Germany

来源：

EUROPEAN UROLOGY | 2024年 / 85卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A0475

引用

页码：S1346 / S1346

页数：1

共 50 条

[21] Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder
Hensley, Patrick J.
Goodwin, Jeffrey
Davenport, Daniel L.
Strup, Stephen E.
James, Andrew
CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E851 - E858
[22] Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma
Krüger, S
Mahnken, A
Kausch, I
Feller, AC
UROLOGY, 2006, 67 (01) : 105 - 109
[23] The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma
Shigeta, Keisuke
Matsumoto, Kazuhiro
Ogihara, Koichiro
Murakami, Tetsushi
Anno, Tadatsugu
Umeda, Kota
Izawa, Mizuki
Baba, Yuto
Sanjo, Tansei
Shojo, Kazunori
Tanaka, Nobuyuki
Takeda, Toshikazu
Kosaka, Takeo
Mizuno, Ryuichi
Mikami, Shuji
Kikuchi, Eiji
Oya, Mototsugu
CANCER SCIENCE, 2021, 112 (03) : 1084 - 1094
[24] Lymphadenectomy for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma
Sathianathen, Niranjan J.
Risk, Michael C.
Konety, Badrinath R.
UROLOGIC CLINICS OF NORTH AMERICA, 2018, 45 (02) : 215 - +
[25] Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma
Basatac, Cem
Aktepe, Fatma
Saglam, Sezer
Akpinar, Haluk
INTERNATIONAL BRAZ J UROL, 2019, 45 (04): : 843 - 846
[26] CANCER STEM CELL MARKER EXPRESSION IN MUSCLE-INVASIVE UROTHELIAL CARCINOMA
Diaz, Edward
Ching, Christina
Elson, Paul
Hansel, Donna
JOURNAL OF UROLOGY, 2011, 185 (04): : E561 - E561
[27] Cancer Stem Cell Marker Expression in Muscle-Invasive Urothelial Carcinoma
Diaz, E.
Ching, C. B.
Elson, P.
Hansel, D. E.
LABORATORY INVESTIGATION, 2011, 91 : 188A - 188A
[28] Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma
Chitikela, Sindhura
Kumar, Lalit
Sahoo, Ranjit K.
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10): : 956 - 956
[29] Adjuvant immunotherapy in muscle-invasive urothelial carcinoma
Funada, Satoshi
Luo, Yan
LANCET ONCOLOGY, 2020, 22 (06): : E236 - E236
[30] Adjuvant immunotherapy in muscle-invasive urothelial carcinoma
Rizzo, Alessandro
Mollica, Veronica
Massari, Francesco
LANCET ONCOLOGY, 2021, 22 (06): : E237 - E237

← 1 2 3 4 5 →